Factors influencing the institutionalization of digital pharmacovigilance tools in LMICs: a scoping review using the non-adoption, abandonment, scale-up, spread, and sustainability framework

BACKGROUND: Digital tools for pharmacovigilance (PV) have been widely promoted to strengthen adverse drug reaction (ADR) reporting in low- and middle-income countries (LMICs). Despite growing evidence on the implementation of digital pharmacovigilance tools, limited evidence has examined the factors influencing their institutionalization in LMICs. This scoping review examines the institutionalization of digital PV tools in LMICs and identifies factors shaping their long-term integration. METHODS: A scoping review was conducted following PRISMA-ScR guidelines. 2 reviewers independently screened studies identified through MEDLINE, Embase, Web of Science, Google Scholar, and selected grey literature. Eligible studies examined digital PV tools implemented in LMICs and reported implementation-related findings. Data were synthesized using an inductive-deductive thematic approach informed by the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework. RESULTS: 21 studies from 14 LMICs were included of which the majority are in sub-Saharan Africa, with fewer studies from South/Southeast Asia, the Middle East, and none from Latin America. Evidence was heavily concentrated on technological features, user adoption, and short-term organizational readiness. Key facilitators included simplified reporting interfaces, offline functionalities, training, and alignment with WHO PV standards. However, persistent barriers were identified at organizational and system levels, including weak or absence of governance, limited feedback mechanisms, fear of blame, fragmented workflows, and heavy reliance on external donor funding. Evidence related to long-term embedding, such as routinization, domestic and sustainable financing, and institutional ownership, was sparse. 16 of 21 included studies (76%) examined tools at the implementation stage (pilot/trial/early routine use), 4 (19%) at the pre-implementation stage, and only 1 (5%) at post-implementation/sustained use. CONCLUSIONS: Digital PV in LMICs is frequently treated as a technical intervention rather than a complex socio-technical and institutional change. Strengthening the long-term integration of digital PV may require greater attention to legal mandates, sustainable financing, organizational and professional capacities, and political commitment.

Authors

Institutions

Publication Details

Journal
International Journal of Medical Informatics
Published
2026-10-14
DOI
https://doi.org/10.1016/j.ijmedinf.2026.106763
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors influencing the institutionalization of digital pharmacovigilance tools in LMICs: a scoping review using the non-adoption, abandonment, scale-up, spread, and sustainability framework

Racha Soubra, Bangaman Christian Akani, Hassane Alami, Pascale Lehoux et al.
International Journal of Medical Informatics
Pharmacovigilance and Adverse Drug Reactions
article

Factors influencing the institutionalization of digital pharmacovigilance tools in LMICs: a scoping review using the non-adoption, abandonment, scale-up, spread, and sustainability framework

Racha Soubra, Bangaman Christian Akani, Hassane Alami, Pascale Lehoux, Soutongnoma Safiata Kabore
article en

Abstract

BACKGROUND: Digital tools for pharmacovigilance (PV) have been widely promoted to strengthen adverse drug reaction (ADR) reporting in low- and middle-income countries (LMICs). Despite growing evidence on the implementation of digital pharmacovigilance tools, limited evidence has examined the factors influencing their institutionalization in LMICs. This scoping review examines the institutionalization of digital PV tools in LMICs and identifies factors shaping their long-term integration. METHODS: A scoping review was conducted following PRISMA-ScR guidelines. 2 reviewers independently screened studies identified through MEDLINE, Embase, Web of Science, Google Scholar, and selected grey literature. Eligible studies examined digital PV tools implemented in LMICs and reported implementation-related findings. Data were synthesized using an inductive-deductive thematic approach informed by the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework. RESULTS: 21 studies from 14 LMICs were included of which the majority are in sub-Saharan Africa, with fewer studies from South/Southeast Asia, the Middle East, and none from Latin America. Evidence was heavily concentrated on technological features, user adoption, and short-term organizational readiness. Key facilitators included simplified reporting interfaces, offline functionalities, training, and alignment with WHO PV standards. However, persistent barriers were identified at organizational and system levels, including weak or absence of governance, limited feedback mechanisms, fear of blame, fragmented workflows, and heavy reliance on external donor funding. Evidence related to long-term embedding, such as routinization, domestic and sustainable financing, and institutional ownership, was sparse. 16 of 21 included studies (76%) examined tools at the implementation stage (pilot/trial/early routine use), 4 (19%) at the pre-implementation stage, and only 1 (5%) at post-implementation/sustained use. CONCLUSIONS: Digital PV in LMICs is frequently treated as a technical intervention rather than a complex socio-technical and institutional change. Strengthening the long-term integration of digital PV may require greater attention to legal mandates, sustainable financing, organizational and professional capacities, and political commitment.

International Journal of Medical InformaticsVol. 223
Institut National d'Excellence en Santé et en Services Sociaux (CA), Université Félix Houphouët-Boigny (CI), Université de Montréal (CA), American University of Beirut (LB)
Fonds de Recherche du Québec - Santé
Good health and well-being
Openalex Percentile: Top 11%
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.